Synergizing Ferroptosis and Immunotherapy via a PROTAC/PDT/HPK1 Inhibitor-Loaded Nanoplatform for Enhanced Antitumor Efficacy

Journal:

Advanced Functional Materials

Published:

2025-07-17

DOI:

10.1002/adfm.202507906

Affiliations:

9

Authors:

9

Go to article

Institutions	Authors	Share
The People's Hospital of Gaozhou, China	3.500000	0.39
Shenzhen Bay Laboratory, China	2.500000	0.28
Shenyang Pharmaceutical University (SPU), China	1.000000	0.11
Southern Medical University (SMU), China	0.500000	0.06
Shidong Hospital Affiliated to University of Shanghai for Science and Technology, China	0.500000	0.06
University of Shanghai for Science and Technology (USST), China	0.500000	0.06
Dongguan People's Hospital, China	0.500000	0.06

Interested in Oncology and Carcinogenesis?